The Future of mRNA Technology

An Evening Dialogue between Science, Medicine and Society Panel Discussion & Film Screening

The COVID-19 pandemic brought mRNA technology to the forefront of global attention — a revolutionary drug class that enabled life-saving vaccines but also sparked public debate. As its vast potential becomes increasingly clear, reaching far beyond infectious diseases into cancer therapy, regenerative medicine, and more, one thing is certain: the future of precision medicine will be shaped by mRNA.

However, technological progress must go hand in hand with public trust, transparent dialogue, and an adaptive regulatory framework.

In this moderated panel discussion, leading voices from science, medicine, regulatory, and industry will explore the origins and future of mRNA medicines — and how to ensure that biomedical innovation truly serves society.

We are delighted to have the following distinguished panelists join us:

• Prof. Katalin Karikó, Nobel Laureate in Physiology or Medicine, pioneer of mRNA technology
• Prof. Leif Erik Sander, Head of Infectious Diseases and Critical Care Medicine, Charité
• Dr. Christoph Conrad, Head of Regulatory Support Unit, BIH (formerly PEI, WHO, BMBF)
• Dr. Patrick Baumhof, Senior Vice President Technology & Innovation, CureVac

The discussion will be moderated by Dr. Norman Drzeniek, Physician-scientist at Charité Department of Rheumatology and Clinical Immunology and group of Experimental Immunotherapy @BIH.

Following the screening of the documentary THE MESSENGER, which offers a fascinating look at the people and ideas behind the development of mRNA technology, we will have a moderated panel discussion with leading voices from science, medicine, regulation, and industry.

Join us and be inspired by insightful perspectives and an open exchange about the future of translational research.